Guaranteeing the Protection of Confidential Data in Drug Registration Files in Israel
This article was originally published in SRA
Executive Summary
This article describes a new guideline that the Pharmaceutical Administration of Israel’s Ministry of Health has issued on the protection of data in drug registration files. The document, released in December 2008, applies to all employees of the Pharmaceutical Administration and the Institute for the Standardisation and Control of Pharmaceuticals (the institute), as well as to relevant external consultants and advisory committee members. It is particularly noteworthy because it is the first-ever issued guideline in Israel in this respect.